This application seeks continued funding for a period of five years for the Cancer Center Support Grant of the University of Southern California Comprehensive Cancer Center. The USC Comprehensive Cancer Center is a separately defined component of the USC School of Medicine. The Center pursues excellence in cancer research, treatment and education through collaborative relationships among its members and with the community. The Cancer Center Program is divided into three divisions, each with a number of program areas; Basic Research; Clinical Investigations; and Cancer Cause and Prevention. The objective of the basic research program areas is to promote interdisciplinary studies on the causes and mechanisms of cancer development and spread through research in virology, cell and molecular biology, chemical carcinogenesis, experimental immunology, and cancer pharmacology, The clinical programs conduct research on effective new methods for cancer diagnosis and management and aim to provide the best possible care for cancer patients at the Norris Cancer Hospital, the LAC-USC Medical Center, the Childrens Hospital of Los Angeles, and the other hospitals affiliated with the Center. The programs in cancer cause and prevention conduct hypothesis based studies of the occurrence of cancer in human populations; develop and apply statistical methods to improve the quality of epidemiological studies and clinical trials; and to design and carry out multidisciplinary studies of methods of cancer prevention, cancer screening, treatment compliance, and patient adaptations to cancer and its treatment. The Cancer Center also actively promotes the education and training of basic scientists, clinicians, clinical investigators, and allied health personnel who deal with cancer. Funds are requested to support the senior leadership, the program coordinators, the administration, the shared facilities and resources, and the continued development of USC Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-15
Application #
3101384
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1980-04-01
Project End
1990-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
15
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753
McSkane, Michelle; Stintzing, Sebastian; Heinemann, Volker et al. (2018) Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study. Clin Colorectal Cancer 17:215-222.e3
Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha et al. (2018) Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. Clin Colorectal Cancer :
Brunette, Laurie L; Mhawech-Fauceglia, Paulette Y; Ji, Lingyun et al. (2018) Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. BMC Cancer 18:970
Poulard, Coralie; Baulu, Estelle; Lee, Brian H et al. (2018) Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death. Cell Death Dis 9:1038
Lang, Julie E; Brownson, Kirstyn E (2018) ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer. Ann Surg Oncol :
Milam, Joel; Slaughter, Rhona; Tobin, Jessica L et al. (2018) Childhood Cancer Survivorship and Substance Use Behaviors: A Matched Case-Control Study Among Hispanic Adolescents and Young Adults. J Adolesc Health 63:115-117
Guo, Yu; Perez, Andrew A; Hazelett, Dennis J et al. (2018) CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome Biol 19:160
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. Pharmacogenomics J 18:623-632
Singh, Hardeep P; Wang, Sijia; Stachelek, Kevin et al. (2018) Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Proc Natl Acad Sci U S A 115:E9391-E9400

Showing the most recent 10 out of 842 publications